Friday, 10 April 2020

Australia News

  • Study visualizes link between gluten and immune system

    Australia |  News | By BioSpectrum Bureau  | 0 Comment | 12 Oct, 2012

    Singapore: A link between gluten and the immune system has literally been visualized in new research published in the scientific journal Immunity. The discovery is the collaborative work of...Read more

  • Phylogica, Cubist evaluate antimicrobial phylomers

    Australia |  News | By BioSpectrum Bureau  | 0 Comment | 26 Jul, 2013

    Singapore: Phylogica is collaborating with Cubist Pharmaceuticals in order to evaluate several of its antimicrobial Phylomers in models of multi-drug resistant bacterial infections. Dr Paul...Read more

  • Kevin Buchi joins Benitec board

    Australia |  Influencers | By BioSpectrum Bureau  | 0 Comment | 11 Apr, 2013

    Singapore: Benitec Biopharma appointed Mr Kevin Buchi to its board of directors. Mr Buchi served as CEO of Cephalon, through its $6.8 billion acquisition by Teva Pharmaceutical Industries i...Read more

  • Osiris successfully defends patent challenge in Australia

    Australia |  Regulatory | By BioSpectrum Bureau  | 0 Comment | 26 Feb, 2013

    Singapore: Osiris Therapeutics, a Columbia-based company focused on developing and marketing stem cell products to treat serious medical conditions, has successfully defended a patent chall...Read more

  • Gene discovery to avoid fatal baby disease

    Australia |  News | By BioSpectrum Bureau  | 0 Comment | 10 Jun, 2013

    Singapore: One of the genes which causes a muscle disease so severe that newborn babies rarely survive beyond a few days has been discovered by an international team of scientists, coordina...Read more

  • Aussie firm gets TGA approval for pancreatic cancer drug

    Australia |  Regulatory | By BioSpectrum Bureau  | 0 Comment | 18 Mar, 2014

    Singapore: Australian biopharmaceutical company, Specialised Therapeutics Australia (STA), has recieved Therapeutic Goods Administration (TGA) approval for ABRAXANE (nanoparticle albumin-bo...Read more

  • AIDS 2014: Bill Clinton urges efficient routes for HIV treatment

    Australia |  Influencers | By BioSpectrum Bureau  | 0 Comment | 24 Jul, 2014

    Singapore: Former US President Bill Clinton addressed delegates at AIDS 2014, 20th International AIDS Conference, that finding more economically efficient ways to respond to HIV is vital to...Read more

  • Starpharma, Makhteshim enter agro collaboration

    Australia |  News | By BioSpectrum Bureau  | 0 Comment | 13 Mar, 2013

    Singapore: Starpharma Holdings and Makhteshim Agan Group announced a collaboration program that will see Starpharma's Priostar dendrimer technology applied to novel crop protection formula...Read more

  • Orthocell gets ASX listing, plans to raise $8mn initially

    Australia |  News | By BioSpectrum Bureau  | 0 Comment | 29 May, 2014

    Singapore: Australian regenerative medicine firm, Orthocell, is looking ahead to raise $8 million through an Initial Public Offer (IPO) of 20 million shares to be listed on the Australian S...Read more

  • Australian prof lauds US nanotech use in diagnostics

    Australia |  News | By BioSpectrum Bureau  | 0 Comment | 17 May, 2012

    Singapore: Professor Justin Cooper-White of the Australian Institute for Bioengineering and Nanotechnology spent a week in the US sharing ideas with defence force researchers in Washington ...Read more

  • Novogen to acquire Triaxial for $1.88 million

    Australia |  News | By BioSpectrum Bureau  | 0 Comment | 20 Nov, 2012

    Singapore: Novogen has agreed to acquire all of the shares of Triaxial Pharmaceuticals for $1.88 million in a combination of the company's ordinary shares and debt based on the achievement ...Read more

  • Sunshine Heart gets unconditional approval from FDA

    Australia |  Regulatory | By BioSpectrum Bureau  | 0 Comment | 21 Nov, 2012

    Singapore: Sunshine Heart, a global medical device company focused on innovative technologies for moderate to severe heart failure, has received unconditional approval from the FDA to comm...Read more

  • CSL makes a settlement in Perth vaccine victim case

    Australia |  News | By BioSpectrum Bureau  | 0 Comment | 09 Jun, 2014

    Singapore: In an ongoing case where Perth-based Ms Saba Button suffered severe disability following a flu vaccine manufactured by Australia's leading biotech firm CSL, the Australian Court ...Read more

  • US, EU, Aussie and Canada together churn $98.8 bn biotech revenue in 2013: EY

    Australia |  Analysis | By BioSpectrum Bureau  | 0 Comment | 24 Apr, 2013

    Singapore: Global biotechnology industry rebounded strongly in 2013, with public companies achieving double-digit revenue growth and a sharp increase in funds raised, according to Ernst &am...Read more

  • Pharmaxis gets grants for fibrotic research

    Australia |  News | By BioSpectrum Bureau  | 0 Comment | 08 Jul, 2013

    Singapore: Australian pharmaceutical company Pharmaxis' research projects conducted in conjunction with the University of Sydney have been awarded funding under the Australian Research Coun...Read more

  • Book Doctor's appointment through an app

    Australia |  News | By BioSpectrum Bureau  | 0 Comment | 24 Apr, 2013

    Singapore: In a bid to provide easier access to primary healthcare services, CQ medicare local has secured funding for the online service provider directory and booking system. The CQ heal...Read more

  • Clinical Network Services acquires Beltas' assets

    Australia |  News | By BioSpectrum Bureau  | 0 Comment | 07 Jan, 2013

    Singapore: Clinical Network Services (CNS), an Australia-based CRO offering integrated development services in the planning, implementation and delivery of phase I and II trials, has acquir...Read more

  • Clinical Network Services acquires BELTAS' business assets

    Australia |  News | By BioSpectrum Bureau  | 0 Comment | 24 Apr, 2013

    Singapore: Australian CRO, Clinical Network Services (CNS), has acquired the business assets of its erstwhile New Zealand partner BELTAS, a CRO based in Auckland. Terms of the deal were not...Read more